Carmello Carlo-Stella (Carmelo Carlo-Stella, C Carlo-Stella)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2013-2024
Publications (10 Years): 44

Top Venues

The New England journal of medicine

British journal of haematology

Cells

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Jacopo Mariotti, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmello Carlo-Stella, Stefania Bramanti, Armando Santoro
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells 13 (2) (2024)
Nicola Lambri, Giorgio Longari, Daniele Loiacono, Ricardo Coimbra Brioso, Leonardo Crespi, Carmela Galdieri, Francesca Lobefalo, Giacomo Reggiori, Roberto Rusconi, Stefano Tomatis, Luisa Bellu, Stefania Bramanti, Elena Clerici, Chiara De Philippis, Damiano Dei, Pierina Navarria, Carmello Carlo-Stella, Ciro Franzese, Marta Scorsetti, Pietro Mancosu
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy. Medical physics 51 (6) (2024)
Carmello Carlo-Stella
Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss. British journal of haematology (2024)
Jacopo Mariotti, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmello Carlo-Stella, Stefania Bramanti, Armando Santoro
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells 13 (2) (2024)
Jacopo Mariotti, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmello Carlo-Stella, Stefania Bramanti, Armando Santoro
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells 13 (2) (2024)
Nicola Lambri, Giorgio Longari, Daniele Loiacono, Ricardo Coimbra Brioso, Leonardo Crespi, Carmela Galdieri, Francesca Lobefalo, Giacomo Reggiori, Roberto Rusconi, Stefano Tomatis, Luisa Bellu, Stefania Bramanti, Elena Clerici, Chiara De Philippis, Damiano Dei, Pierina Navarria, Carmello Carlo-Stella, Ciro Franzese, Marta Scorsetti, Pietro Mancosu
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy. Medical physics (2024)
Carmello Carlo-Stella
Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss. British journal of haematology 205 (1) (2024)
Jacopo Mariotti, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmello Carlo-Stella, Stefania Bramanti, Armando Santoro
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells 13 (2) (2024)
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S Kahl, Weiyun Z Ai, John Radford, Melham M Solh, Kirit M Ardeshna, Brian T Hess, Matthew A Lunning, Pier Luigi Luigi Zinzani, Anastasios Stathis, Carmello Carlo-Stella, Izidore S Lossos, Paolo F Caimi, Sunwoo Han, Fei Yang, Russ A Kuker, Craig H Moskowitz
PET/CT-biomarkers enable risk stratification of patients with relapsed/refractory diffuse large B-cell lymphoma enrolled in the LOTIS-2 clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Damiano Dei, Nicola Lambri, Sara Stefanini, Veronica Vernier, Ricardo Coimbra Brioso, Leonardo Crespi, Elena Clerici, Luisa Bellu, Chiara De Philippis, Daniele Loiacono, Pierina Navarria, Giacomo Reggiori, Stefania Bramanti, Marcello Rodari, Stefano Tomatis, Arturo Chiti, Carmello Carlo-Stella, Marta Scorsetti, Pietro Mancosu
Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation. Cancers 15 (5) (2023)
Damiano Dei, Nicola Lambri, Sara Stefanini, Veronica Vernier, Ricardo Coimbra Brioso, Leonardo Crespi, Elena Clerici, Luisa Bellu, Chiara De Philippis, Daniele Loiacono, Pierina Navarria, Giacomo Reggiori, Stefania Bramanti, Marcello Rodari, Stefano Tomatis, Arturo Chiti, Carmello Carlo-Stella, Marta Scorsetti, Pietro Mancosu
Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation. Cancers 15 (5) (2023)
Paolo F Caimi, Mehdi Hamadani, Carmello Carlo-Stella, Masoud Nickaeen, Eric Jordie, Kiersten Utsey, Tim Knab, Francesca Zammarchi, Danilo Cucchi, Serafino Pantano, Karin E Havenith, Ying Wang, Joseph Boni
In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine. EJHaem 5 (1) (2023)
Nicola Lambri, Simone Leopoldo Antonetti, Damiano Dei, Luisa Bellu, Stefania Bramanti, Ricardo Coimbra Brioso, Carmello Carlo-Stella, Isabella Castiglioni, Elena Clerici, Leonardo Crespi, Chiara De Philippis, Carmela Galdieri, Daniele Loiacono, Pierina Navarria, Giacomo Reggiori, Roberto Rusconi, Stefano Tomatis, Marta Scorsetti, Pietro Mancosu
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment. Current oncology (Toronto, Ont.) 30 (4) (2023)
Nicola Lambri, Simone Leopoldo Antonetti, Damiano Dei, Luisa Bellu, Stefania Bramanti, Ricardo Coimbra Brioso, Carmello Carlo-Stella, Isabella Castiglioni, Elena Clerici, Leonardo Crespi, Chiara De Philippis, Carmela Galdieri, Daniele Loiacono, Pierina Navarria, Giacomo Reggiori, Roberto Rusconi, Stefano Tomatis, Marta Scorsetti, Pietro Mancosu
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment. Current oncology (Toronto, Ont.) 30 (4) (2023)
Eleonora Calabretta, Martina di Trani, Francesco Corrado, Martina Sollini, Vanessa Cristaldi, Fabrizio Marino, Lodovico Terzi di Bergamo, Alessio Bruscaggin, Maria Cristina Pirosa, Stefania Bramanti, Arturo Chiti, Davide Rossi, Carmello Carlo-Stella
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma. British journal of haematology (2023)
Nicola Lambri, Simone Leopoldo Antonetti, Damiano Dei, Luisa Bellu, Stefania Bramanti, Ricardo Coimbra Brioso, Carmello Carlo-Stella, Isabella Castiglioni, Elena Clerici, Leonardo Crespi, Chiara De Philippis, Carmela Galdieri, Daniele Loiacono, Pierina Navarria, Giacomo Reggiori, Roberto Rusconi, Stefano Tomatis, Marta Scorsetti, Pietro Mancosu
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment. Current oncology (Toronto, Ont.) 30 (4) (2023)
Paolo F Caimi, Mehdi Hamadani, Carmello Carlo-Stella, Masoud Nickaeen, Eric Jordie, Kiersten Utsey, Tim Knab, Francesca Zammarchi, Danilo Cucchi, Serafino Pantano, Karin E Havenith, Ying Wang, Joseph Boni
In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine. EJHaem 5 (1) (2023)
Eleonora Calabretta, Mehdi Hamadani, Pier Luigi Zinzani, Paolo Caimi, Carmello Carlo-Stella
The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma. Blood 140 (4) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Eleonora Calabretta, Anna Guidetti, Francesca Ricci, Martina Di Trani, Chiara Monfrini, Massimo Magagnoli, Stefania Bramanti, Davide Maspero, Lucia Morello, Michele Merli, Alice Di Rocco, Alex Graudenzi, Enrico Derenzini, Marco Antoniotti, Davide Rossi, Paolo Corradini, Armando Santoro, Carmello Carlo-Stella
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics. British journal of haematology 198 (1) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Reid W Merryman, Luca Castagna, Laura Giordano, Vincent T Ho, Paolo Corradini, Anna Guidetti, Beatrice Casadei, David A Bond, Samantha M Jaglowski, Michael A Spinner, Sally Arai, Robert Lowsky, Gunjan L Shah, Miguel-Ángel Perales, Jean Marc Schiano De Colella, Didier Blaise, Alex F Herrera, Geoffrey Shouse, Chloe Spilleboudt, Stephen M Ansell, Yago Nieto, Talha Badar, Mehdi Hamadani, Tatyana A Feldman, Lori Dahncke, Anurag K Singh, Joseph P McGuirk, Taiga Nishihori, Julio Chavez, Anthony V Serritella, Justin Kline, Mohamad Mohty, Rémy Duléry, Aspasia Stamatoulas, Roch Houot, Guillaume Manson, Marie-Pierre Moles-Moreau, Corentin Orvain, Kamal Bouabdallah, Dipenkumar Modi, Radhakrishnan Ramchandren, Lazaros Lekakis, Amer Beitinjaneh, Matthew J Frigault, Yi-Bin Chen, Ryan C Lynch, Stephen D Smith, Uttam Rao, Michael Byrne, Jason T Romancik, Jonathon B Cohen, Sunita Nathan, Tycel Phillips, Robin M Joyce, Maryam Rahimian, Asad Bashey, Hatcher J Ballard, Jakub Svoboda, Valter Torri, Martina Sollini, Chiara De Philippis, Massimo Magagnoli, Armando Santoro, Philippe Armand, Pier Luigi Luigi Zinzani, Carmello Carlo-Stella
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma. Leukemia 35 (9) (2021)
Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmello Carlo-Stella, Fritz C Offner, Anna Sureda, Gilles Andre Salles, Joaquín Martínez-Lopez, Michael Crump, Denise N Thomas, Peter N Morcos, Cristiano Ferlini, Ann-Marie E Bröske, Anton Belousov, Marina Bacac, Natalie Dimier, David J Carlile, Linda Lundberg, David Perez-Callejo, Pablo Umaña, Tom Moore, Martin Weisser, Michael J Dickinson
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Eleonora Calabretta, Jose M Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O'Gorman, Antonio Pagliuca, Clifton Mo, Rebecca M Baron, Alessio Aghemo, Robert Soiffer, Jawed Fareed, Carmello Carlo-Stella, Paul Richardson
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. British journal of haematology 193 (1) (2021)
Monica Balzarotti, Massimo Magagnoli, Miguel Ángel Canales, Paolo Corradini, Carlos Grande, Juan-Manuel Sancho, Francesco Zaja, Anne-Marie Quinson, Valérie Belsack, Daniela Maier, Carmello Carlo-Stella
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma. Investigational new drugs 39 (4) (2021)
Mehdi Hamadani, John Radford, Carmello Carlo-Stella, Paolo F Caimi, Erin G Reid, Owen A O'Connor, Jay M Feingold, Kirit M Ardeshna, William Townsend, Melhem Solh, Leonard T Heffner, David Ungar, Luqiang Wang, Joseph Boni, Karin Havenith, Yajuan Qin, Brad S Kahl
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma. Blood 137 (19) (2021)
Martina Sollini, Fabrizia Gelardi, Carmello Carlo-Stella, Arturo Chiti
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect". European journal of nuclear medicine and molecular imaging 48 (8) (2021)
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W Friedberg, Martin Dreyling, Brad Kahl, Mats Jerkeman, Mohamed A Kharfan-Dabaja, Frederick L Locke, Mazyar Shadman, Brian T Hill, Sairah A Ahmed, Alex F Herrera, Craig S Sauter, Veronika Bachanova, Nilanjan Ghosh, Matthew Lunning, Vaishalee P Kenkre, Mahmoud Aljurf, Michael L Wang, Kami J Maddocks, John P Leonard, Manali Kamdar, Tycel Phillips, Amanda F Cashen, David J Inwards, Anna Sureda, Jonathon B Cohen, Sonali M Smith, Carmello Carlo-Stella, Bipin Savani, Stephen P Robinson, Timothy S Fenske
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma. Bone marrow transplantation 56 (12) (2021)
Margarita Kirienko, Gaia Ninatti, Luca Cozzi, Emanuele Voulaz, Nicolò Gennaro, Isabella Barajon, Francesca Ricci, Carmello Carlo-Stella, Paolo Zucali, Martina Sollini, Luca Balzarini, Arturo Chiti
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas. La Radiologia medica 125 (10) (2020)
Luca Castagna, Armando Santoro, Carmello Carlo-Stella
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and Outcomes. Journal of blood medicine 11 (2020)
Roberto Ronca, Gaia C Ghedini, Federica Maccarinelli, Antonio Sacco, Silvia L Locatelli, Eleonora Foglio, Sara Taranto, Elisabetta Grillo, Sara Matarazzo, Riccardo Castelli, Giuseppe Paganini, Vanessa Desantis, Nadia Cattane, Annamaria Cattaneo, Marco Mor, Carmello Carlo-Stella, Angelo Belotti, Aldo M Roccaro, Marco Presta, Arianna Giacomini
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress. Cancer research 80 (11) (2020)
Martina Sollini, Margarita Kirienko, Lara Cavinato, Francesca Ricci, Matteo Biroli, Francesca Ieva, Letizia Calderoni, Elena Tabacchi, Cristina Nanni, Pier Luigi Zinzani, Stefano Fanti, Anna Guidetti, Alessandra Alessi, Paolo Corradini, Ettore Seregni, Carmello Carlo-Stella, Arturo Chiti
Methodological framework for radiomics applications in Hodgkin's lymphoma. European journal of hybrid imaging 4 (1) (2020)
Eleonora Calabretta, Carmello Carlo-Stella
The Many Facets of CD38 in Lymphoma: From Tumor-Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy. Cells 9 (4) (2020)
Eleonora Calabretta, Francesco d'Amore, Carmello Carlo-Stella
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma. International journal of molecular sciences 20 (21) (2019)
Brad S Kahl, Mehdi Hamadani, John Radford, Carmello Carlo-Stella, Paolo Caimi, Erin Reid, Jay M Feingold, Kirit M Ardeshna, Melhem Solh, Leonard T Heffner, David Ungar, Shui He, Joseph Boni, Karin Havenith, Owen A O'Connor
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (23) (2019)
Marco Righi, Silvia Laura Locatelli, Carmello Carlo-Stella, Marco Presta, Arianna Giacomini
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors. Scientific reports 8 (1) (2018)
Antonino Carbone, Annunziata Gloghini, Carmello Carlo-Stella
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? Blood 132 (1) (2018)
S L Locatelli, G Careddu, G Inghirami, L Castagna, P Sportelli, A Santoro, Carmello Carlo-Stella
The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. Leukemia 30 (12) (2016)
M Magni, M Di Nicola, C Patti, R Scimè, A Mulè, A Rambaldi, T Intermesoli, P Viero, C Tarella, A Gueli, L Bergui, L Trentin, A Barzan, F Benedetti, A Ambrosetti, F Di Raimondo, A Chiarenza, G Parvis, A Billio, I Attolico, A Olivieri, M Montanari, Carmello Carlo-Stella, P Matteucci, L Devizzi, A Guidetti, S Viviani, P Valagussa, A M Gianni
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis. Bone marrow transplantation 49 (4) (2014)
S L Locatelli, L Cleris, G G Stirparo, S Tartari, E Saba, M Pierdominici, W Malorni, A Carbone, A Anichini, Carmello Carlo-Stella
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts. Leukemia 28 (9) (2014)
L Farina, A Guidetti, F Spina, L Roncari, P Longoni, F Ravagnani, Carmello Carlo-Stella, P Corradini
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF. Bone marrow transplantation 49 (3) (2013)

Carmello Carlo-Stella.css-eqlu8i{font-size:small;padding-left:4px;} (Carmelo Carlo-Stella, C Carlo-Stella)

Publication Activity (10 Years)

Top Topics

Top Venues

Carmello Carlo-Stella (Carmelo Carlo-Stella, C Carlo-Stella)